SEATTLE, June 01, 2021, (MEDGADGET) — Overview:
A transcriptome is a set of all the transcripts found in a single cell or a population of cells. Both forms of ribonucleic acid (RNA) molecules, including messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding RNA molecules, are included in transcripts.
Statistics:
The global transcriptomics technologies market is expected to account around US$ 15,569.1 Mn in terms of value by the end of 2027.
Drivers
Rising acceptance and offerings of novel microarrays is expected to drive growth of the global transcriptomics technologies market during the forecast period. For instance, in March 2020, Agilent Technologies Inc. launched Agilent GenetiSure Cyto microarrays for prenatal and postnatal research.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/3989
Moreover, initiatives to advance personalized medicine are also expected to aid in growth of the global transcriptomics technologies market. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.
Statistics:
North America held dominant position in the global transcriptomics technologies market in 2019, accounting around 39.2% share in terms of value, followed by Europe and Asia Pacific, respectively.
Restraints
Shortage of appropriate data collection tools is expected to hamper global transcriptomics technologies market growth. With the development in technology, there has been a growing concern about data complexity post transcript analysis from sequencing platforms. One of the most important problems in transcriptome research is data management. The data difficulty grows with advancements in subsequent RNA research methodology.
Furthermore, the global transcriptomics technologies market growth is expected to be hindered by the complex processes involved in isolating RNA from the tissue of interest.
Opportunities
Rising incidence of cancer is expected to drive growth for global transcriptomics technologies market players over the forecast period. For instance, in 2019, according to the American Cancer Society, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Moreover, the advancement of emerging technology is also expected to propel growth of the global transcriptomics technologies market. For instance, in December 2019, PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology.
Market Segmentation
- By Technology Type: Microarrays, PCR, Gene Regulation Technologies, Next Generation Sequencing.
- By Application: Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, and Comparative Transcriptomics.
Statistics
The global transcriptomics technologies market was valued at US$ 4,625.8 Mn in 2019 and is forecast to reach a value of US$ 15,569.1 Mn by 2027 at a CAGR of 16.4% between 2020 and 2027.
Market Trends/Key Takeaways
Key market players are now focusing on the acceptance and launching of new products due to broaden their product range. For instance, in May 2019, Siemens Healthineers launched its new Atellica CH Enzymatic Hemoglobin A1C Assay to for diagnosing and monitoring diabetes.
The market’s major players are also focusing on merger & acquisitions approaches to broaden their product range. For instance, in April 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., a developer of instruments and consumables for the isolation, detection, and analysis of single cells.
Competitive Landscape
Key players operating in the global transcriptomics technologies market such as, Agilent Technologies, Inc., Affymetrix, Inc., Inc., Danaher Corporation, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Illumina, Inc., Life Technologies Corporation, LLC, Qiagen N.V. and LC Sciences.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3989
Key Developments
Key players in the global transcriptomics technologies market are concentrating on collaboration strategies to broaden their product portfolio. For instance, in March 2020, Illumina, Inc. partnered with IDbyDNA Inc., a metagenomics technology company, for R&D of next-generation sequencing-based workflows.
Key market players are now focusing on the acceptance and launching of new products in order to broaden their product range. For instance, in June 2018, Agilent Technologies Inc. received the U.S. Food and Drug Administration (FDA) approval for its Dako PD-L1 IHC 22C3 pharmDx assay used for determining PD-L1 expression in cervical cancer.
Detailed Segmentation:
- Global Transcriptomics Technologies Market, By Technology:
- Microarrays
- PCR
- Gene Regulation Technologies
- Next Generation Sequencing
- Global Transcriptomics Technologies Market, By Application:
- Clinical Diagnostics
- Drug Discovery & Research
- Bioinformatics
- Comparative Transcriptomics
- Global Transcriptomics Technologies Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/transcriptomics-technologies-market-3257
Other Related Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837